Vaccine

Gritstone bio to Host Virtual KOL Event to Discuss Unmet Need and Potential Role of Its Personalized Cancer Vaccine, GRANITE, in Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

-- Event will feature Dr. Randolph Hecht (Professor, UCLA GI Oncology Program) and Howard Brown (CRC Survivor, Patient and Advocate)…

5 months ago

OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis

OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis Lusvertikimab…

5 months ago

Defence Therapeutics Granted CNRI-H from the Canadian Nuclear Laboratories to Accelerate the Development of Its Radio-Immuno-Conjugates Program

Vancouver, British Columbia--(Newsfile Corp. - July 24, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

5 months ago

Sleep Apnea Devices Market worth $9.3 billion by 2029 driven by Rising Technological Advancements | MarketsandMarkets™

CHICAGO, July 23, 2024 /PRNewswire/ -- The global Sleep Apnea Devices Market is expected to grow from USD 6.5 billion in…

5 months ago

Alcami unveils new conditions and services at state-of-the-art pharma storage facility in Garner

Central North Carolina pharma storage facility now offers extensive cold and stability conditions plus full suite of material support services…

5 months ago

David Rubenstein Joins Moderna’s Board of Directors

Co-Founder and Co-Chairman of The Carlyle Group brings multi-industry investor experience and global policy expertise, replacing retiring director Stephen BerensonCo-founder…

5 months ago

Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024

GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday,…

5 months ago

Kiniksa Pharmaceuticals Reports Second Quarter 2024 Financial Results and Recent Portfolio Execution

– ARCALYST® (rilonacept) Q2 2024 net product revenue of $103.4 million, representing 90% year-over-year growth –– ARCALYST 2024 expected net…

5 months ago

Stowers scientists uncover fundamental rules for how dengue virus infects its mosquito and human hosts

The new research provides hope for identifying future therapeutic approaches KANSAS CITY, Mo., July 22, 2024 /PRNewswire/ -- Mosquito-borne viral…

5 months ago

AmpleLogic Turns 15; Marked in an Evening Filled with Celebrations and Inspiration

HYDERABAD, India, July 22, 2024 /PRNewswire/ -- AmpleLogic, a leader in providing GAMP (Good Automated Manufacturing Practices) solutions, celebrated its…

5 months ago